Skip to Content

Kadcyla Prices, Coupons and Patient Assistance Programs

Kadcyla (ado-trastuzumab emtansine) is a member of the HER2 inhibitors drug class and is commonly used for Breast Cancer, and Breast Cancer - Metastatic.

Kadcyla Prices

The cost for Kadcyla intravenous powder for injection 100 mg is around $3,451 for a supply of 1 powder for injection, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.

This Kadcyla price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.

Intravenous Powder For Injection

Drugs.com Printable Discount Card

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Kadcyla Coupons and Rebates

Kadcyla offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.

Kadcyla Genentech Oncology Co-pay Assistance Program: Eligible commercially insured patients may pay $5 in out-of-pocket costs for the prescribed product; annual savings of up to $25,000 per year; for additional information contact the program at 855-692-6729.

Applies to:
Kadcyla
Number of uses:
per prescription per calendar year

Form more information phone: 855-692-6729 or Visit website

Kadcyla Genentech Oncology Co-pay Assistance Program Rebate:Eligible commercially insured patients enrolled in the program may be entitled to a rebate for their out-of-pocket cost if they paid the provider directly for treatment; for additional information contact the program at 855-692-6729.

Applies to:
Kadcyla
Number of uses:
One rebate per prescription fill

Form more information phone: 855-692-6729 or Visit website

Patient Assistance Programs for Kadcyla

Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.

Provider: Patient Access Network Foundation (PAN)

Elligibility requirements:
  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. FDA Approved Diagnosis - See Program Website for Details
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
  • Kadcyla (ado-trastuzumab emtansine) Injection; IV

More information please phone: 866-316-7263 Visit Website

Provider: Genentech Access Solutions Oncology

Elligibility requirements:
  1. Determined case by case
  2. Based on FPL
  3. Varies
  4. Must be treated by US licensed healthcare provider
  5. Call for most recent medications as the list is subject to change. Eligibility determined on a case-by-case basis. Contact program for details.
Applicable drugs:
  • Kadcyla (ado-trastuzumab emtansine) Injection; IV

More information please phone: 888-249-4918   or 866-422-2377   Visit Website

Provider: Genentech Patient Foundation

Elligibility requirements:
  1. Uninsured or Underinsured with no prescription coverage for needed medication
  2. Income Guidelines published on Program Website
  3. Medically appropriate condition/diagnosis
  4. Must be treated by US licensed healthcare provider
  5. The Genentech Access to Care Foundation is now the Genentech Patient Foundation. Eligibility determined on a case-by-case basis. Call for most recent medications as the list is subject to change.
Applicable drugs:
  • Kadcyla (ado-trastuzumab emtansine) Injection; IV

More information please phone: 888-941-3331 Visit Website